December 27, 2014 7:42 PM ET

Capital Markets

Company Overview of Weinberg Capital Partners

Executive Profile

Serge Weinberg

Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 11 different industries.

See Board Relationships
63€708,040
As of Fiscal Year 2013

Background

Mr. Serge Weinberg Founded Weinberg Capital Partners in 2005 and serves as its President, Partner and Chairman. Mr. Weinberg has been the Chief Executive Officer and Chairman of La Redoute since July 1995. He has been the Chief Executive Officer and Chairman of FNAC since July 1995. Mr. Weinberg has been Interim Chief Executive Officer of Sanofi since October 29, 2014. Prior to that, he spent ten years as Chief Executive Officer of Kering (formerly PPR). Mr. Weinberg ...

Corporate Headquarters

20 rue Quentin Bauchart
Paris, Ile-de-France 75008

France

Phone: 33 1 53 53 55 00
Fax: 33 1 53 53 55 19

Board Members Memberships

Director
Former Chairman, Chairman of Strategy Committee, Member of Compensation & Appointments Committee and Member of Corporate Governance Committee
Former Director and Chairman of Nomination and Compensation Committee
Former Director
Founder, President, Partner, and Chairman
Partner and Chairman
1992-N/A
Vice Chairman
1998-N/A
Former Director
2005-N/A
Former Independent Director, Chairman of Human Resources & Social Responsibility Committee and Member of Governance Committee
2009-Present
Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee

Education

Bachelor's Degree
Ecole Nationale d'Administration Publique
Unknown/Other Education 1976
Ecole Nationale D'Administration

Other Affiliations

Annual Compensation

Salary€700,000
Total Annual Compensation€700,000

Stocks Options

All Other Compensation€8,040

Total Compensation

Total Annual Cash Compensation€708,040
Total Short Term Compensation€700,000
Other Long Term Compensation€8,040
Total Calculated Compensation€708,040
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
$2.9M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Weinberg Capital Partners, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.